Paulo Ricardo Criado

Dr. Criado holds a medical degree from the ABC Foundation (1989). He completed a Masters in Clinical Medicine, by the Institute of Medical Assistance to the State Public Servant (2002). Doctorate in the Department of Dermatology of the Faculty of Medicine of the University of São Paulo (FMUSP) in 2007. Approved for Habilitation (venia legendi) in Dermatology by the Faculty of Medicine of the University of São Paulo in 2015. Full researcher at the Faculdade de Medicina do ABC. It has 251 complete articles published in national and international indexed journals, of which 192 are in Pubmed / Medline, and 1 accepted for publication. He is the author of 139 chapters of national books and 9 chapters in English. Editor of the book TEXTBOOK OF DERMATOLOGY, by Atheneu Publisher, in its 4th Edition. In 2014 he edited the book Adverse Drug Reactions: Dermatological Spectrum in Clinical Practice, edited by Manole, ISBN 978-85-204-3887-9. Peer reviewer of 78 national and international medical journals. President of the Brazilian Society of Dermatology - Regional of the State of São Paulo in 2013-2014. In 2016 he published the book Diseases of Vessels and Hypercoagulability in the Skin, by Editora Atheneu. Conceived and created FUNADERSP, a support and research support body at SBD-RESP in 2008. He created and coordinated the Education Campaign on Solar Exposure in Childhood (Sol, Childhood Friend) in partnership with the Monica Group (Mauricio de Sousa Productions) that reached more than 200,000 children in the State of São Paulo. Register of speciality qualification (RQE) in Dermatology number 37489 / CREMESP 66343. Publons, https://publons.com/researcher/1184230/paulo-ricardo-criado/publications/Awarded a Research Productivity Scholarship by CNPq (PQ2) in 2017, 2020, 2023. Proponent of CNPq development project. Certification received by Ga2LEN (Global Allergy and Asthma European Network) for our private office Alergoskin as an ACARE (Angioedema Centers of Reference and Excellence), UCARE (Urticaria Centers of Reference and Excellence) and ADCARE (Atopic Dermatitis Centers of Reference and Excellence), all certifications as network of skills by European Academy of Allergy and Clinical Immunology. Clinical Research (CLINICAL TRIALS) in dermatology speciality for Schering-Plough, Novartis, Lilly, Sanofi, Pfizer and AMGEN. Competed couse of Good Clinical Practice in 2022. (Source: Lattes Curriculum)